Han Y - Search Results

1

ENPP2 promotes progression and lipid accumulation via AMPK/SREBP1/FAS pathway in chronic lymphocytic leukemia.

Lu L, Hu X, Han Y, Wang H, Tian Z, Zhang Y, Wang X. Lu L, et al. Among authors: han y. Cell Mol Biol Lett. 2024 Dec 27;29(1):159. doi: 10.1186/s11658-024-00675-6. Cell Mol Biol Lett. 2024. PMID: 39731014 Free PMC article.

2

Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51.

Han Y, Hu X, Yun X, Liu J, Yang J, Tian Z, Zhang X, Zhang Y, Wang X. Han Y, et al. Cell Death Dis. 2021 Nov 15;12(11):1083. doi: 10.1038/s41419-021-04368-2. Cell Death Dis. 2021. PMID: 34782617 Free PMC article.

3

CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia.

Hu X, Han Y, Liu J, Wang H, Tian Z, Zhang X, Zhang Y, Wang X. Hu X, et al. Among authors: han y. Exp Hematol Oncol. 2023 Jan 12;12(1):6. doi: 10.1186/s40164-022-00364-0. Exp Hematol Oncol. 2023. PMID: 36635772 Free PMC article.

4

The emerging roles of KPNA2 in cancer.

Han Y, Wang X. Han Y, et al. Life Sci. 2020 Jan 15;241:117140. doi: 10.1016/j.lfs.2019.117140. Epub 2019 Dec 6. Life Sci. 2020. PMID: 31812670 Review.

5

Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model.

Zhang X, Han Y, Hu X, Wang H, Tian Z, Zhang Y, Wang X. Zhang X, et al. Among authors: han y. Biomark Res. 2022 Oct 21;10(1):75. doi: 10.1186/s40364-022-00423-y. Biomark Res. 2022. PMID: 36271413 Free PMC article.

6

Chen X, Hu S, Han Y, Cai Y, Lu T, Hu X, Chu Y, Zhou X, Wang X. Chen X, et al. Among authors: han y. Clin Exp Med. 2023 Oct;23(6):2601-2617. doi: 10.1007/s10238-023-00996-4. Epub 2023 Jan 22. Clin Exp Med. 2023. PMID: 36682001

7

KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.

Chen X, Lu T, Cai Y, Han Y, Ding M, Chu Y, Zhou X, Wang X. Chen X, et al. Among authors: han y. Cell Mol Biol Lett. 2023 Apr 19;28(1):32. doi: 10.1186/s11658-023-00445-w. Cell Mol Biol Lett. 2023. PMID: 37076815 Free PMC article.

8

AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma.

Sang T, Yang J, Liu J, Han Y, Li Y, Zhou X, Wang X. Sang T, et al. Among authors: han y. Cancer Gene Ther. 2021 Nov;28(10-11):1125-1135. doi: 10.1038/s41417-020-00258-5. Epub 2021 Jan 7. Cancer Gene Ther. 2021. PMID: 33414519 Free PMC article.

9

Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma.

Zhao Y, Yang J, Liu J, Cai Y, Han Y, Hu S, Ren S, Zhou X, Wang X. Zhao Y, et al. Among authors: han y. Cell Death Dis. 2021 Jun 23;12(7):640. doi: 10.1038/s41419-021-03919-x. Cell Death Dis. 2021. PMID: 34162828 Free PMC article.

10

PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma.

Zhang X, Han Y, Nie Y, Jiang Y, Sui X, Ge X, Liu F, Zhang Y, Wang X. Zhang X, et al. Among authors: han y. J Mol Med (Berl). 2023 May;101(5):595-606. doi: 10.1007/s00109-023-02313-8. Epub 2023 May 1. J Mol Med (Berl). 2023. PMID: 37126184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,071 results

Search Page

Filters